Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02866877 · ClinicalTrials.gov registry record
Effects of Augmented Renal Clearance on Pharmacokinetic and Pharmacodynamic Properties of Levetiracetam in Subarachnoid Hemorrhage
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 15
- Enrollment target
NCT02866877 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 15 participants.
The verdict
NCT02866877 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
This study evaluates the pharmacokinetic profile of levetiracetam in critically ill patients who have suffered a subarachnoid hemorrhage. The patients will be evaluated for development of augmented renal clearance and the effects and duration of effects this may have on levetiracetam clearance.
Interventions
- OTHER Pharmacokinetic modeling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2016-01 |
| Est. Completion | 2021-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02866877
The ClinicalTrials.gov registry entry for NCT02866877 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pharmacokinetic modeling is the first listed.
NCT02866877 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02866877 about?
NCT02866877 is a clinical study titled "Effects of Augmented Renal Clearance on Pharmacokinetic and Pharmacodynamic Properties of Levetiracetam in Subarachnoid Hemorrhage". This study evaluates the pharmacokinetic profile of levetiracetam in critically ill patients who have suffered a subarachnoid hemorrhage. The patients will be evaluated for development of augmented renal clearance and the effects and duration of effects this may have on levetiracetam clearance.
What is the current status of trial NCT02866877?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2016-01. Estimated completion is 2021-03.
What interventions are being tested in trial NCT02866877?
The interventions under investigation include: Pharmacokinetic modeling (OTHER).
Who is sponsoring clinical trial NCT02866877?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.